Evaluation of association of HNF1B variants with diverse cancers: Collaborative analysis of data from 19 genome-wide association studies

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Elliott, Katherine S ^a   Zeggini, Eleftheria ^a,b   McCarthy, Mark I ^a,c   Gudmundsson, Julius ^d   Sulem, Patrick ^d   Stacey, Simon N ^d   Thorlacius, Steinunn ^d   Amundadottir, Laufey ^e   Grönberg, Henrik ^f   Xu, Jianfeng ^g   Gaborieau, Valerie ^h   Eeles, Rosalind A ⁱ   Neal, David E ^b   Donovan, Jenny L ^j   Hamdy, Freddie C ^c   Muir, Kenneth ^k   Hwang, Shih Jen ^l   Spitz, Margaret R ^m   Zanke, Brent ^n,o   Carvajal Carmona, Luis ^a   Brown, Kevin M ^p   Hayward, Nicholas K ^q   Macgregor, Stuart ^q   Tomlinson, Ian P M ^a   Lemire, Mathieu ⁿ   Amos, Christopher I ^m   Murabito, Joanne M ^r   Isaacs, William B ^s   Easton, Douglas F ^b   Brennan, Paul ^h   Barkardottir, Rosa B ^t,u   Gudbjartsson, Daniel F ^d   Rafnar, Thorunn ^d   Hunter, David J ^v,af   Chanock, Stephen J ^e   Stefansson, Kari ^d   Ioannidis, John P A ^w,x   Mann, Graham J ^y   Hopper, John L ^z   Aitken, Joanne F ^aa   Kefford, Richard F ^y   Giles, Graham G ^ab   Armstrong, Bruce K ^ac   Petersen, Gloria M ^ad   Fuchs, Charles S ^ae,af   Kraft, Peter ^v   Stolzenberg Solomon, Rachael Z ^e   Jacobs, Kevin B ^e,ag,ah   Arslan, Alan A ^ai,aj   Bas Bueno De Mesquita, H ^ak,al   Gallinger, Steven ^am   Gross, Myron ^an   Helzlsouer, Kathy ^ao   Holly, Elizabeth A ^ap   Jacobs, Eric J ^aq   Klein, Alison P ^ar,as   Lacroix, Andrea ^at   Li, Donghui ^au   Mandelson, Margaret T ^at,av   Olson, Sara H ^aw   Risch, Harvey A ^ax   Zheng, Wei ^ay   Albanes, Demetrius ^e   Bamlet, William R ^ad   Berg, Christine D ^e   Boutron Ruault, Marie Christine ^az   Buring, Julie E ^af   Bracci, Paige M ^ap   Canzian, Federico ^ba   Clipp, Sandra ^as   Cotterchio, Michelle ^bb   de Andrade, Mariza ^ad   Duell, Eric J ^bc   Michael Gaziano, J ^af,bd   Giovannucci, Edward L ^v,af   Goggins, Michael ^ar   Hallmans, Göran ^be   Hankinson, Susan E ^v,af   Hassan, Manal ^au   Howard, Barbara ^bf   Hutchinson, Amy ^e,ag   Jenab, Mazda ^bc   Kaaks, Rudolf ^ba   Kooperberg, Charles ^at   Krogh, Vittorio ^bg   Kurtz, Robert C ^aw   Lynch, Shannon M ^e   McWilliams, Robert R ^ad   Mendelsohn, Julie B ^e   Michaud, Dominique S ^v,bh   Parikh, Hemang ^e   Patel, Alpa V ^aq   Peeters, Petra H M ^al,bh   Rajkovic, Aleksandar ^bi   Riboli, Elio ^bh   Rodriguez, Laudina ^bj   Seminara, Daniela ^e   Shu, Xiao Ou ^ay   Thomas, Gilles ^e,az   Tjønneland, Anne ^bk   Tobias, Geoffrey S ^e   Trichopoulos, Dimitrios ^v,bl   Van Den Eeden, Stephen K ^bm   Virtamo, Jarmo ^bn   Wactawski Wende, Jean ^bo   Wang, Zhaoming ^e,ag   Wolpin, Brian M ^ae,af   Yu, Herbert ^ax   Yu, Kai ^e   Zeleniuch Jacquotte, Anne ^ai,aj   Fraumeni, Joseph F ^e   Hoover, Robert N ^e   Hartge, Patricia ^e   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d DECODE GENETICS   (Iceland)

^e NATIONAL CANCER INSTITUTE   (United States)

^f KAROLINSKA INSTITUTE   (Sweden)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

^h INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

ⁱ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^j UNIVERSITY OF BRISTOL   (United Kingdom)

^k UNIVERSITY OF WARWICK   (United Kingdom)

^l NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^m UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁿ ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^o OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^p TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^q ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^r BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s DEPARTMENT OF PATHOLOGY   (United States)

^t LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^u UNIVERSITY OF ICELAND   (Iceland)

^v HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^w UNIVERSITY OF IOANNINA   (Greece)

^x TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^y UNIVERSITY OF SYDNEY   (Australia)

^z UNIVERSITY OF MELBOURNE   (Australia)

^aa VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^ab CANCER EPIDEMIOLOGY CENTRE   (Australia)

^ac UNIVERSITY OF SYDNEY   (Australia)

^ad Mayo Clinic College of Medicine   (United States)

^ae DANA FARBER CANCER INSTITUTE   (United States)

^af HARVARD MEDICAL SCHOOL   (United States)

^ag SAIC FREDERICK INC   (United States)

^ah Bioinformed Consulting Services   (United States)

^ai NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aj NEW YORK UNIVERSITY   (United States)

^ak NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^al UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^am MOUNT SINAI HOSPITAL   (Canada)

^an UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^ao MERCY MEDICAL CENTER   (United States)

^ap UNIVERSITY OF CALIFORNIA   (United States)

^aq AMERICAN CANCER SOCIETY   (United States)

^ar JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^as JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^at USA   (United States)

^au UNIVERSITY OF TEXAS   (United States)

^av CENTER FOR HEALTH STUDIES   (United States)

^aw MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^ax YALE UNIVERSITY   (United States)

^ay VANDERBILT INGRAM CANCER CENTER   (United States)

^az INSERM   (France)

^ba GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^bb UNIVERSITY OF TORONTO   (Canada)

^bc CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^bd VETERANS AFFAIRS MEDICAL CENTER   (United States)

^be UMEÅ UNIVERSITY   (Sweden)

^bf GEORGETOWN UNIVERSITY   (United States)

^bg NATIONAL CANCER INSTITUTE   (Italy)

^bh IMPERIAL COLLEGE LONDON   (United Kingdom)

^bi UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^bj Health and Health Care Services Council   (Spain)

^bk DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^bl BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^bm KAISER PERMANENTE   (United States)

^bn NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^bo UNIVERSITY AT BUFFALO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1BETA;

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER RISK; COLORECTAL CANCER; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LUNG CANCER; MELANOMA; PANCREAS CANCER; PHENOTYPE; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

EID: 77956530101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010858     Document Type: Article

References (48)

1. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, et al. (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166: 1871-1877.
2. Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, et al. (2007) Prospective study of hyperglycemia and cancer risk. Diabetes Care 30: 561-567.
3. Rousseau MC, Parent ME, Pollak MN, Siemiatycki J (2006) Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 118: 2105-2109.
4. Kasper JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15: 2056-2062.
5. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, et al. (2006) Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 15: 1977-1983.
6. Calton BA, Chang SC, Wright ME, Kipnis V, Lawson K, et al. (2007) History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control 18: 493-503.
7. Will JC, Vinicor F, Calle EE (1999) Is diabetes mellitus associated with prostate cancer incidence and survival? Epidemiology 10: 313-318.
8. Manolio TA, Brooks LD, Collins FS (2008) A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118: 1590-1605.
9. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, et al. (2007) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39: 977-983.
10. Sun J, Zheng SL, Wiklund F, Isaacs SD, Purcell LD, et al. (2008) Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet 40: 1153-1155.
11. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, et al. (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet.
12. Winckler W, Weedon MN, Graham RR, McCarroll SA, Purcell S, et al. (2007) Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes. Diabetes 56: 685-693.
13. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, et al. (1997) Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 17: 384-385.
14. Tenesa A, Farrington SM, Prendergast JG, Porteous ME, Walker M, et al. (2008) Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 40: 631-637.
15. Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, et al. (2008) Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci USA 105: 4340-4345.
16. Maris JM, Mosse YP, Bradfield JP, Hou C, Monni S, et al. (2008) Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. N Engl J Med 358: 2585-2593.
17. Cust AE, Schmid H, Maskiell JA, Jetann J, Ferguson M, et al. (2009) Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study. Am J Epidemiol 170: 1541-1554.
18. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, et al. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40: 316-321.
19. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, et al. (2010) A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 42: 224-228.
20. Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, et al. (2007) Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case con trol study. Hum Mol Genet 16: 1794-1801.
21. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633-637.
22. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40: 616-622.
23. Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, et al. (2007) Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 39: 989-994.
24. Brown KM, Macgregor S, Montgomery GW, Craig DW, Zhao ZZ, et al. (2008) Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet 40: 838-840.
25. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39: 645-649.
26. Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, et al. (2007) Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst 99: 1836-1844.
27. Tomlinson IP, Webb E, Carvajal-Carmona L, Broderick P, Howarth K, et al. (2008) A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 40: 623-630.
28. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, et al. (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40: 703-706.
29. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 41: 221-227.
30. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638-642.
31. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39: 631-637.
32. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, et al. (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet.
33. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
34. http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000007.v9.p4.
35. Edghill EL, Bingham C, Ellard S, Hattersley AT (2006) Mutations in hepatocyte nuclear factor-1beta and their related phenotypes. J Med Genet 43: 84-90.
36. Rebouissou S, Vasiliu V, Thomas C, Bellanne-Chantelot C, Bui H, et al. (2005) Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas. Hum Mol Genet 14: 603-614.
37. Reber M, Cereghini S (2001) Variant hepatocyte nuclear factor 1 expression in the mouse genital tract. Mech Dev 100: 75-78.
38. Coffinier C, Barra J, Babinet C, Yaniv M (1999) Expression of the vHNF1/ HNF1beta homeoprotein gene during mouse organogenesis. Mech Dev 89: 211-213.
39. Ioannidis JP, Thomas G, Daly MJ (2009) Validating, augmenting and refining genome-wide association signals. Nat Rev Genet 10: 318-329.
40. Yamada H, Penney KL, Takahashi H, Katoh T, Yamano Y, et al. (2009) Replication of prostate cancer risk loci in a Japanese case-control association study. J Natl Cancer Inst 101: 1330-1336.
41. Levin AM, Machiela MJ, Zuhlke KA, Ray AM, Cooney KA, et al. (2008) Chromosome 17q12 variants contribute to risk of early-onset prostate cancer. Cancer Res 68: 6492-6495.
42. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, et al. (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40: 638-645.
43. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316: 1336-1341.
44. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106: 9362-9367.
45. Kavvoura FK, Ioannidis JP (2008) Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet 123: 1-14.
46. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Bmj 327: 557-560.
47. Ioannidis JP, Patsopoulos NA, Evangelou E (2007) Uncertainty in heterogeneity estimates in meta-analyses. Bmj 335: 914-916.
48. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet.